Indirect ELISA developed to detect antibodies against Mycoplasma synoviae P50 protein via immunoproteomic screening

Yang Liu, Guangju You, Jianzhou Shi, Li Gao, Xiaoqi Li, Hong Cao, Yongqiang Wang, Shijun J ZhengApplied Microbiology and Biotechnology 2025 · DOI

Abstract

Mycoplasma synoviae (MS) infection is a chronic disease of poultry with significant economic impacts. An efficient diagnostic tool for MS infection is in great demand. This study aimed to develop a novel indirect enzyme-linked immunosorbent assay (iELISA) method based on antigens identified by pull-down assay combined with mass spectrometry. Using these methods and anti-MS serum, we identified an uncharacterized protein with a molecular weight of 53 kDa (named P50 protein) and then established a recombinant P50 protein-based ELISA (rP50-ELISA) to detect antibodies against P50 protein. A receiver operating characteristic (ROC) analysis was performed to estimate the optical density (OD) cut-off value that maximized the sensitivity (Se) and specificity (Sp) of the rP50-ELISA, which had a mean Se of 93% (95% CI = 86.25-96.57%) and a mean Sp of 100% (95% CI = 91.80-100%), with an area under the curve (AUC) of 0.9979 (95% CI = 99.41-100%). The rP50-ELISA showed no cross-reactivity with antibodies against other avian pathogens. Serum samples from 164 clinical chickens were tested with the rP50-ELISA, and the results revealed a high concordance rate of 93.29% with commercial diagnostic kits.

Introduction

Mycoplasma synoviae (MS) is a major bacterial pathogen in the poultry industry, causing respiratory disease, infectious synovitis, and eggshell apex abnormalities. These conditions lead to significant economic losses due to reduced growth rates, increased condemnation at slaughter, and decreased egg production. Early and accurate detection is critical for managing flock health, yet current serological methods like serum plate agglutination (SPA) and hemagglutination inhibition (HI) often lack the necessary sensitivity or specificity for universal application.

While commercial ELISAs are available, many utilize the major surface protein B (MSPB) as a primary antigen. However, MSPB is known for its high antigenic variability across different MS strains, which can lead to false negatives in diagnostic testing. This study sought to identify a highly conserved and immunogenic protein to serve as a more reliable diagnostic target for a universal MS ELISA.

Materials and Methods

The researchers employed an immunoproteomic strategy to identify potential diagnostic antigens. Initially, a pull-down assay was performed using antibodies from MS-infected chickens to isolate proteins from MS bacterial extracts. These proteins were then characterized using liquid chromatography-mass spectrometry (LC-MS/MS).

Figure 1: Immunoproteomic screening and identification of MS antigens. (A, B) SDS-PAGE analysis of pull-down proteins. (C) Mass spectrometry profile of identified peptides. (D) Gene Ontology (GO) enrichment analysis of the identified proteins.

From the mass spectrometry results, 18 high-scoring proteins were selected for further evaluation. Eight of these were successfully cloned and expressed in E. coli. Their antigenicity was screened using a Dot-ELISA against MS-positive chicken serum. An uncharacterized 53 kDa protein, designated "P50," exhibited the strongest reactivity and was selected for the development of the indirect ELISA (rP50-ELISA). The assay conditions, including coating concentration and blocking buffers, were optimized via checkerboard titration.

Results

The diagnostic performance of the rP50-ELISA was rigorously validated using ROC analysis to determine an optimal cut-off value. The assay achieved a mean sensitivity of 93% and a specificity of 100%, with an AUC of 0.9979, indicating excellent diagnostic accuracy.

Crucially, the rP50-ELISA demonstrated zero cross-reactivity with sera positive for other common avian pathogens, including Mycoplasma gallisepticum (MG), Newcastle Disease Virus (NDV), and Avian Influenza (AIV). In a clinical evaluation of 164 field samples, the rP50-ELISA showed a 93.29% concordance rate with a standard commercial IDEXX kit. Notably, the P50-based assay significantly outperformed an experimental ELISA based on the traditional MSPB antigen, which only achieved 60.37% concordance on the same clinical set.

Discussion

The success of the P50 protein as a diagnostic antigen is largely attributed to its high conservation (97.59–100%) across various MS strains, addressing the limitations of variable antigens like MSPB. Bioinformatics suggests P50 is a secreted protein, a class of proteins often associated with high immunogenicity in Mycoplasma species.

One challenge noted during development was that several high-scoring proteins from the initial screening failed to react in the Dot-ELISA after recombinant expression in E. coli. This likely resulted from the loss of conformational epitopes during the prokaryotic expression process, suggesting that alternative expression systems might be needed to fully explore the diagnostic potential of other identified proteins.

Conclusion

The developed rP50-ELISA provides a highly sensitive, specific, and reliable tool for detecting MS antibodies. Its reliance on a conserved antigen makes it suitable for broad-scale surveillance and eradication programs, offering a robust alternative to current strain-sensitive diagnostics in the poultry industry.

Summary updated

Abstract

Mycoplasma synoviae infection is a chronic disease of poultry with significant economic impacts. An efficient diagnostic tool for M. synoviae infection is in great demand. This study aimed to develop a novel indirect enzyme-linked immunosorbent assay (iELISA) method based on antigens identified by pull-down assay combined with mass spectrometry. Using these methods and anti-M. synoviae serum, we identified an uncharacterized protein with a molecular weight of 53 kDa (named P50 protein) and then established a recombinant P50 protein-based ELISA (rP50-ELISA) to detect antibodies against P50 protein. A receiver operating characteristic (ROC) analysis was performed to estimate the optical density (OD) cut-off value that maximized the sensitivity (Se) and specificity (Sp) of the rP50-ELISA, which had a mean Se of 93% (95% confidence interval (CI) = 86.25-96.57%) and a mean Sp of 100% (95% CI = 91.80-100%), with an area under the curve (AUC) of 0.9979 (95% CI = 99.41-100%). The rP50-ELISA showed no cross-reactivity with antibodies against other avian pathogens. Serum samples from 164 clinical chickens were tested with the rP50-ELISA, and the results revealed a high concordance rate of 93.29% with commercial diagnostic kits. KEY POINTS: • Screening for the major antigen of M. synoviae for ELISA development. • The P50 protein was selected as a coating antigen for ELISA. • rP50-ELISA was successfully developed for detecting anti-M. synoviae antibodies with high sensitivity and specificity.
BibTeX
@inproceedings{liu2025indirect,
  author = {Yang Liu and Guangju You and Jianzhou Shi and Li Gao and Xiaoqi Li and Hong Cao and Yongqiang Wang and Shijun J Zheng},
  title = {{Indirect ELISA developed to detect antibodies against Mycoplasma synoviae P50 protein via immunoproteomic screening}},
  booktitle = {Applied Microbiology and Biotechnology},
  year = {2025},
  doi = {10.1007/s00253-025-13503-4},
}
Figure